Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a revised proxy form for the 2025 Annual General Meeting scheduled on 29 May 2026. The update addresses typographical and formatting adjustments only, with no substantive changes to the original content.

The original proxy form dated 23 April 2026 is now void. Shareholders who previously submitted that version must complete and lodge the newly released form. Submission methods, deadlines, and all other related requirements remain unchanged; detailed instructions are provided in the revised document.

The updated proxy form is available on the websites of Hong Kong Exchanges and Clearing Limited (www.hkexnews.hk) and the company (www.livzon.com.cn). Livzon Pharma has apologized for any inconvenience caused by the formatting adjustments.